Inventor · disambiguated record
Mathieu Lepage
Also filed as: LEPAGE MATHIEU · LEPAGE MATHIEU L
2 granted patents·2 pending applications·4 citations·filing 2017–2021
45Inventor score
Files withBRITISH COLUMBIA CANCER AGENCY BRANCH1EPIC VENTURES INC1PROVINCIAL HEALTH SERVICES AUTHORITY1XLYNX MAT INC1
Top patents by PatentIndex Score
4 records- 0180US10882871B218/19F-labelled compounds which target the prostate specific membrane antigenBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Granted Jan 5, 2021·3 cites·20 claims
- 0272US12427209B2Dual mode 18F-labelled theranostic compounds and uses thereofPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted Sep 30, 2025·1 cites·5 claims
- 0347US2022281820A1Diazirine-based molecules and uses thereofXLYNX MAT INC·Filed 2020·Application pending·0 cites
- 0441US2023136109A1Light-activated pathogen-killing molecules and uses thereofEPIC VENTURES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathieu Lepage files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →